Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Plos One
|
April 7, 2010
Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients
Cathy J Jensen, Jim Stankovich, Anneke Van der Walt, et al.
Human Molecular Genetics
|
March 2, 2010
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis
Kaushal S Gandhi, Fiona C McKay, Mathew Cox, et al.
Life Science Alliance
|
June 11, 2020
Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells
Melissa M Gresle, Margaret A Jordan, Jim Stankovich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 30, 2012
A genome-wide association study in progressive multiple sclerosis
Filippo Martinelli-Boneschi, Federica Esposito, Paola Brambilla, et al.
Plos One
|
November 5, 2010
A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis
Judith Field, Sharon R Browning, Laura J Johnson, et al.
Human Molecular Genetics
|
July 19, 2015
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis
Ben J Gu, Judith Field, Sébastien Dutertre, et al.
American Journal of Human Genetics
|
March 1, 2008
Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis
Samuel F Berkovic, Leanne M Dibbens, Alicia Oshlack, et al.
Brain : a Journal of Neurology
|
November 30, 2022
Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity
Vilija G Jokubaitis, Maria Pia Campagna, Omar Ibrahim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 8, 2021
Prediction of multiple sclerosis outcomes when switching to ocrelizumab
Michael Zhong, Anneke van der Walt, Jim Stankovich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 1, 2019
Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype
Yuan Zhou, Suzi B Claflin, Jim Stankovich, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Plos One
|
April 7, 2010
Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients
Cathy J Jensen, Jim Stankovich, Anneke Van der Walt, et al.
Human Molecular Genetics
|
March 2, 2010
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis
Kaushal S Gandhi, Fiona C McKay, Mathew Cox, et al.
Life Science Alliance
|
June 11, 2020
Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells
Melissa M Gresle, Margaret A Jordan, Jim Stankovich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 30, 2012
A genome-wide association study in progressive multiple sclerosis
Filippo Martinelli-Boneschi, Federica Esposito, Paola Brambilla, et al.
Plos One
|
November 5, 2010
A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis
Judith Field, Sharon R Browning, Laura J Johnson, et al.
Human Molecular Genetics
|
July 19, 2015
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis
Ben J Gu, Judith Field, Sébastien Dutertre, et al.
American Journal of Human Genetics
|
March 1, 2008
Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis
Samuel F Berkovic, Leanne M Dibbens, Alicia Oshlack, et al.
Brain : a Journal of Neurology
|
November 30, 2022
Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity
Vilija G Jokubaitis, Maria Pia Campagna, Omar Ibrahim, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 8, 2021
Prediction of multiple sclerosis outcomes when switching to ocrelizumab
Michael Zhong, Anneke van der Walt, Jim Stankovich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 1, 2019
Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype
Yuan Zhou, Suzi B Claflin, Jim Stankovich, et al.
Page
of 9